NCT00156117View on ClinicalTrials.gov

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

PHASE3CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

May 12, 2005

Primary Completion Date

April 28, 2006

Study Completion Date

May 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

asenapine

5 mg BID or 10mg BID

DRUG

Placebo

Placebo

DRUG

olanzapine

olanzapine 15 mg QD

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00156117 - Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) | Biotech Hunter | Biotech Hunter